antigen
character
dot
blot
use
mab
either
target
antigen
site
ii
share
surfac
pref
postf
motavizumab
epitop
uniqu
pref
fig
show
four
antibodi
recogn
freshli
purifi
rsv
firsv
recogn
motavizumab
fig
experi
use
conform
stabil
prefus
f
protein
pref
specif
antibodi
abl
recogn
incub
without
addit
formalin
indic
loss
recognit
firsv
pref
specif
antibodi
due
chemic
modif
formalin
rather
due
modif
pref
conform
investig
effect
formalin
antigen
recognit
increas
concentr
ad
formalin
found
recognit
postf
motavizumab
antibodi
greatli
reduc
supplementari
fig
indic
formalin
influenc
antigen
effect
discern
formalininactiv
concentr
much
less
impact
temperatur
understand
effect
formalin
elev
temperatur
antigen
profil
rsv
virion
recapitul
method
use
manufactur
firsv
defin
kinet
antibodi
reactiv
immedi
applic
formalin
rsv
retain
pref
postf
antigen
site
howev
time
pref
specif
epitop
surfac
rsv
disappear
fig
disappear
pref
specif
epitop
particularli
site
correl
reduct
infect
determin
flow
cytometri
recombin
gfpexpress
rsvinfect
cell
fig
similar
correl
diminish
trimer
bind
loss
infect
observ
viru
incub
differ
temperatur
rang
presenc
formalin
fig
b
reactiv
motavizumab
remain
rel
stabl
everi
temperatur
viru
incub
close
room
temperatur
maintain
pref
epitop
bind
longer
virus
incub
human
bodi
temperatur
mous
bodi
temperatur
data
indic
pref
surfac
virion
convert
postf
quickli
temperatur
room
temperatur
hour
origin
firsv
remain
pref
class
fusion
protein
rsv
f
share
properti
surfac
glycoprotein
envelop
virus
parainfluenza
viru
fusion
f
influenza
hemagglutinin
ha
envelop
env
ebola
glycoprotein
gp
coronaviru
spike
protein
mediat
membran
fusion
conform
chang
prefus
form
transit
prehairpin
intermedi
form
eventu
stabl
bundl
postfus
form
therefor
defin
protein
conform
present
surfac
viral
immunogen
key
understand
mechan
antibodi
neutral
repres
import
step
toward
design
vaccin
immunogen
target
function
prefus
conform
recent
work
env
demonstr
contrast
strainspecif
antibodi
rais
monom
nonn
trimer
stabil
version
prefus
env
trimer
preferenti
elicit
conformationdepend
crossreact
antibodi
effect
target
function
prefus
similarli
critic
differ
antigen
site
pref
infecti
rsv
postf
firsv
suggest
balanc
f
conform
state
determin
viru
infect
design
immunogen
preserv
neutralizationsensit
epitop
function
form
viral
protein
promot
induct
protect
antibodi
respons
diminish
nonneutr
antibodi
respons
theoret
reduc
likelihood
immun
complex
format
complement
activ
studi
mice
macaqu
shown
stabil
pref
immunogen
elicit
potent
neutral
antibodi
respons
titer
high
end
achiev
recurr
natur
infect
hour
time
use
make
firsv
vaccin
presenc
prefspecif
epitop
virion
surfac
membran
nearli
complet
lost
fig
contradict
origin
presumpt
product
firsv
rsv
alter
infect
viru
antigen
low
concentr
formalin
would
help
preserv
fix
antigen
site
catastroph
failur
tragedi
result
firsv
vaccin
trail
restrict
consider
use
proteinbas
rsv
vaccin
infant
defin
atomiclevel
detail
rsv
f
two
distinct
conform
well
isol
character
mab
distinguish
surfac
uniqu
function
pref
nonfunct
postf
provid
new
reagent
defin
antigen
firsv
addit
piec
firsvinduc
vaccineenhanc
diseas
puzzl
anticip
vaccin
design
base
understand
relationship
conform
state
specif
immun
respons
guid
develop
effect
vaccin
rsv
potenti
viral
diseas
antigen
character
perform
dot
blot
use
mab
either
target
antigen
site
ii
share
surfac
pref
postf
motavizumab
epitop
uniqu
pref
surfac
briefli
dot
pref
postf
heat
inactiv
pref
hipref
formalin
inactiv
pref
fipref
rsv
firsv
appli
nitrocellulos
membran
probe
antibodi
motavizumab
made
hous
similarli
western
blot
probe
hrpconjug
secondari
antibodi
reactiv
either
human
goat
antihuman
igghrp
santa
cruz
biotechnolog
mous
rabbit
antimous
igghrp
jackson
immunoresearch
fc
hi
fipref
incub
hour
fipref
includ
concentr
formalin
pref
includ
concentr
formalin
antibodi
incub
one
hour
room
temperatur
skim
milk
tbst
concentr
antibodi
bind
detect
via
gbox
gel
imag
syngen
densitometri
done
use
genetool
syngen
antibodi
bind
postf
virion
report
rel
antibodi
bind
pref
protein
load
control
manufactur
firsv
requir
rsv
expos
formalin
hour
produc
firsv
incub
rsv
formalin
hour
virus
sampl
antigen
analysi
infect
everi
hour
hourinterv
incub
rsv
express
gfp
strain
incub
concentr
formalin
sampl
period
infect
infect
monitor
function
gfp
express
encod
viral
genom
hour
post
infect
flow
cytometri
lsr
ii
bd
bioscienc
ca
usa
prior
assess
flow
cytometri
cell
treat
mm
edta
ensur
singlecel
suspens
optim
analysi
fix
paraformaldehyd
one
hundr
percent
infect
repres
number
cell
infect
rsv
prior
incub
cite
articl
killikelli
et
al
prefus
f
absent
surfac
formalininactiv
respiratori
syncyti
viru
sci
rep
doi
